Viñuela-Berni Verónica, Carbajo-Mata María Antonieta, Corona Rebeca, Morales Teresa
Laboratorio de Neuroanatomía Funcional y Neuroendocrinología, Instituto de Neurobiología (INB), Universidad Nacional Autónoma de México (UNAM), Juriquilla, Querétaro, México.
Laboratorio Universitario de Bioterio, Instituto de Neurobiología (INB), Universidad Nacional Autónoma de México (UNAM), Juriquilla, Querétaro, México.
Sci Rep. 2025 Jul 24;15(1):26905. doi: 10.1038/s41598-025-06143-1.
The high incidence of chronic kidney disease (CKD) requires the refinement of animal models for its study. Adenine-induced CKD model has emerged as a non-invasive model that can replicate human CKD. Historically, most studies employ adenine through the diet. However, the lack of details regarding the preparation makes reproducibility difficult. This study aimed to identify the best approach to induce CKD through adenine administration in C-57BL/6J female mice: oral gavage or via their standard pelleted diet. After 4 weeks of both routes of adenine administration, plasma creatinine and urea levels were increased, while both parameters in urine were decreased, the pellet group showing increased plasma creatinine levels compared with the gavage group and urea levels showing the opposite trend. Both adenine administration routes demonstrated histological changes in the kidney tissues, particularly tubular dilation and necrotic debris. Gavage adenine-induced CKD showed greater tubular dilation compared to the pelleted administration. Adenine treatment increased water intake and urine output, with no differences between administration routes. Finally, a significant decrease in body weight loss and food intake was observed in the pelleted administration compared to the oral gavage administration. Our results suggest that the oral gavage model is less aggressive, with a more linear progression in kidney lesioning, thus providing an even greater opportunity for veterinary oversight and intervention when needed. Therefore, administering adenine by oral gavage is more suitable to induce a stable and reproducible model of CKD in C-57BL/6J female mice.
慢性肾脏病(CKD)的高发病率要求完善其研究用动物模型。腺嘌呤诱导的CKD模型已成为一种可复制人类CKD的非侵入性模型。从历史上看,大多数研究通过饮食给予腺嘌呤。然而,制备方法缺乏细节使得可重复性较差。本研究旨在确定在C-57BL/6J雌性小鼠中通过给予腺嘌呤诱导CKD的最佳方法:口服灌胃还是通过其标准颗粒饲料。在两种腺嘌呤给药途径进行4周后,血浆肌酐和尿素水平升高,而尿液中的这两个参数降低,颗粒饲料组的血浆肌酐水平高于灌胃组,尿素水平呈现相反趋势。两种腺嘌呤给药途径均显示肾组织有组织学变化,特别是肾小管扩张和坏死碎片。与颗粒饲料给药相比,灌胃给予腺嘌呤诱导的CKD显示出更大程度的肾小管扩张。腺嘌呤治疗增加了水摄入量和尿量,给药途径之间无差异。最后,与口服灌胃给药相比,颗粒饲料给药时体重减轻和食物摄入量显著减少。我们的结果表明,口服灌胃模型的侵袭性较小,肾损伤进展更具线性,因此在需要时提供了更大的兽医监督和干预机会。因此,通过口服灌胃给予腺嘌呤更适合在C-57BL/6J雌性小鼠中诱导稳定且可重复的CKD模型。